ARVN Q4 2018 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena

ARVNArvinas, Inc.

$856M

Q4 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M+33.7% YoY

Gross Profit

$3M100.0% margin

Operating Income

-$17M-492.5% margin

Net Income

-$16M-467.6% margin

EPS (Diluted)

$-0.52

QoQ Revenue Growth

+1.9%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$13M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$199M

Total Liabilities

$63M

Stockholders' Equity

$137M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$3M	+33.7%
Gross Profit	$3M	$3M	+33.7%
Operating Income	-$17M	-$5M	-219.3%
Net Income	-$16M	-$5M	-240.3%